Page last updated: 2024-09-05

isospaglumic acid and Degenerative Diseases, Central Nervous System

isospaglumic acid has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Morland, C; Nordengen, K1
Bergeron, R; Khacho, P; Wang, B1

Reviews

2 review(s) available for isospaglumic acid and Degenerative Diseases, Central Nervous System

ArticleYear
    International journal of molecular sciences, 2022, Jan-23, Volume: 23, Issue:3

    Topics: Animals; Brain; Brain Diseases; Brain Injuries, Traumatic; Dipeptides; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Mental Disorders; Neurodegenerative Diseases; Neurons; Neurotransmitter Agents; Receptors, Metabotropic Glutamate

2022
The Good and Bad Sides of NAAG.
    Advances in pharmacology (San Diego, Calif.), 2016, Volume: 76

    Topics: Animals; Brain; Dipeptides; Glutamic Acid; HEK293 Cells; Humans; Neurodegenerative Diseases; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate

2016